$21.85
1.53% yesterday
NYSE, Jun 11, 10:13 pm CET
ISIN
US49177J1025
Symbol
KVUE
Index
Sector
Industry

Kenvue Stock price

$21.85
-2.15 8.96% 1M
-0.37 1.67% 6M
+0.50 2.34% YTD
+3.38 18.30% 1Y
-5.05 18.77% 5Y
-5.05 18.77% 10Y
-5.05 18.77% 20Y
NYSE, Closing price Wed, Jun 11 2025
+0.33 1.53%
ISIN
US49177J1025
Symbol
KVUE
Index
Sector
Industry

Key metrics

Market capitalization $41.95b
Enterprise Value $49.63b
P/E (TTM) P/E ratio 39.73
EV/FCF (TTM) EV/FCF 34.23
EV/Sales (TTM) EV/Sales 3.24
P/S ratio (TTM) P/S ratio 2.74
P/B ratio (TTM) P/B ratio 4.17
Dividend yield 3.71%
Last dividend (FY24) $0.81
Revenue growth (TTM) Revenue growth -1.19%
Revenue (TTM) Revenue $15.30b
EBIT (operating result TTM) EBIT $2.62b
Free Cash Flow (TTM) Free Cash Flow $1.45b
Cash position $1.06b
EPS (TTM) EPS $0.55
P/E forward 22.56
P/S forward 2.69
EV/Sales forward 3.18
Short interest 2.24%
Show more

Is Kenvue a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,842 stocks worldwide.

Kenvue Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Kenvue forecast:

4x Buy
20%
16x Hold
80%

Analyst Opinions

20 Analysts have issued a Kenvue forecast:

Buy
20%
Hold
80%

Financial data from Kenvue

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
15,302 15,302
1% 1%
100%
- Direct Costs 6,399 6,399
4% 4%
42%
8,903 8,903
1% 1%
58%
- Selling and Administrative Expenses 5,845 5,845
6% 6%
38%
- Research and Development Expense 407 407
1% 1%
3%
3,231 3,231
9% 9%
21%
- Depreciation and Amortization 609 609
2% 2%
4%
EBIT (Operating Income) EBIT 2,622 2,622
10% 10%
17%
Net Profit 1,056 1,056
29% 29%
7%

In millions USD.

Don't miss a Thing! We will send you all news about Kenvue directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Kenvue Stock News

Neutral
Accesswire
3 days ago
PHILADELPHIA, PA / ACCESS Newswire / June 9, 2025 / Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning Kenvue Inc. (NYSE:KVUE) on behalf of the company's long-term investors. Click here to receive additional information about your legal rights and options: https://kaskelalaw.com/case/kenvue/ Recently a securities fraud complaint was filed aga...
Positive
Seeking Alpha
8 days ago
I initiate Kenvue with a 'Buy' rating and a $26 fair value, citing its iconic brands and steady dividend appeal. Kenvue's global operations, diversified product lines, and strong R&D enable resilience and ongoing margin expansion through cost efficiencies. Short-term headwinds from China destocking and tariffs are manageable, with long-term organic growth expected to normalize at 4.5%.
Positive
Seeking Alpha
8 days ago
Most Dividend Kings are currently overpriced, but six offer fair value where annual dividends from $1,000 invested exceed their share price. Three top-yield Dividend Kings—Altria, Northwest Natural, and Canadian Utilities—meet the ideal 'dogcatcher' standard for fair pricing and dividend safety. Analyst projections suggest select Dividend Kings could deliver up to 58% total returns by June 2026...
More Kenvue News

Company Profile

Kenvue, Inc. engages in the provision of healthcare products services. It operates through the following business segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care and hair, sun and others. The Essential Health segment includes oral care, baby care, women’s health and wound care. The company was founded on February 23, 2022 and is headquartered in Skillman, NJ.

Head office United States
CEO Thibaut Mongon
Employees 22,000
Website www.kenvue.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today